Vellridge

AI software for biopharma

Better intelligence for decisions that shape access.

Vellridge builds focused AI software for commercial teams—connecting clinical evidence, market context, and access requirements so experts can move from complexity to decision.

Discuss a workflow See where we help

Built for global market access, HEOR, evidence, and commercial strategy.

A connected evidence system

Clinical evidence Access decision
HTA HEOR RWE Pricing Launch

Evidence → insight → access

01

Domain-aware. Built around the language, evidence, and decision points of life sciences.

02

Source-grounded. Designed so experts can trace, challenge, and improve every output.

03

Workflow-first. Focused on the work that matters, not AI for its own sake.

Where we help

Built for the decisions behind market access.

The commercial path begins well before launch. We design software that helps teams bring access questions into development earlier—and carry evidence forward with less friction.

01 Pre-launch

Evidence strategy & development alignment

Surface implications for comparators, endpoints, subgroups, patient outcomes, real-world evidence, and economic models while development choices can still be shaped.

  • Evidence-gap and requirement mapping
  • Comparator and endpoint intelligence
  • Integrated evidence planning
02 Global

Market access & HTA workflows

Turn fragmented global requirements and evidence into transparent, repeatable workflows for assessment, submission, adaptation, and expert review.

  • HTA and payer landscape intelligence
  • Dossier and value-story development
  • Evidence reuse across local markets
03 Launch & lifecycle

Commercial intelligence & planning

Connect clinical, access, pricing, and competitive signals for clearer scenarios, stronger launch readiness, and faster learning across the product lifecycle.

  • Launch and indication scenario planning
  • Pricing and access intelligence
  • Post-launch evidence activation

Biopharma complexity

One asset. Many evidence questions. No room for a black box.

Standards of care move. Evidence expectations differ by market. Launch windows are unforgiving. And advanced therapies can raise the stakes around uncertainty, durability, and affordability.

Vellridge pairs software engineering with market-access fluency to build tools that fit these realities: specific enough to create leverage, and transparent enough to earn expert trust.

How we work

Start with the decision, then build the software.

  1. 01

    Find the high-leverage workflow

    We map the decision, inputs, handoffs, review points, and cost of the current process.

  2. 02

    Build with your experts

    We combine AI and conventional software around your standards, evidence, and operating context.

  3. 03

    Validate for real use

    We design for traceability, expert review, and measurable value before expanding the solution.

A practical place to start

Bring us the workflow your team knows should work better.

We’ll help frame the decision, identify the right role for AI, and define a focused first build.

Start a conversation